You are here

neurologists

Survey puts spotlight on US neurologists’ response to CMS Alzheimer drugs decision

Biopharma Reporter

Mon, 05/16/22 - 10:48 am

monoclonal antibodies

Alzheimer's disease

Argenx's Vygart launch finds quick neurologist support over AstraZeneca's well-entrenched Soliris for myasthenia gravis

Fierce Pharma

Thu, 02/17/22 - 11:13 pm

myasthenia gravis

So far, so not-so-good: Neurologists slow to warm up to Biogen’s Alzheimer drug Aduhelm, study finds

Fierce Pharma

Tue, 07/13/21 - 11:43 pm

Alzheimer's disease

Allergan's Botox still a physician favorite for migraine despite CGRP push: analyst

Fierce Pharma

Fri, 02/21/20 - 10:49 am

How can Teva's migraine drug face off Amgen and Lilly? Put neurologists first, DTC last, executive says

Fierce Pharma

Tue, 05/14/19 - 04:55 pm

Teva Pharmaceutical

DTC advertising